Mitochondrial dysfunction in diabetic cardiomyopathy

被引:163
|
作者
Duncan, Jennifer G. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2011年 / 1813卷 / 07期
关键词
Diabetes; Insulin resistance; Heart failure; Cardiomyopathy; Mitochondria; Oxidative stress; Metabolism; ACTIVATED RECEPTOR-ALPHA; MYOCARDIAL SUBSTRATE METABOLISM; FATTY-ACID OXIDATION; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; REDUCED CARDIAC EFFICIENCY; GLYCATION END-PRODUCTS; PPAR-ALPHA; INSULIN-RESISTANCE; UNCOUPLING PROTEINS; ENERGY-METABOLISM;
D O I
10.1016/j.bbamcr.2011.01.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiovascular disease is common in patients with diabetes and is a significant contributor to the high mortality rates associated with diabetes. Heart failure is common in diabetic patients, even in the absence of coronary artery disease or hypertension, an entity known as diabetic cardiomyopathy. Evidence indicates that myocardial metabolism is altered in diabetes, which likely contributes to contractile dysfunction and ventricular failure. The mitochondria are the center of metabolism, and recent data suggests that mitochondrial dysfunction may play a critical role in the pathogenesis of diabetic cardiomyopathy. This review summarizes many of the potential mechanisms that lead to mitochondrial dysfunction in the diabetic heart. This article is part of a Special Issue entitled: Mitochondria and Cardioprotection. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1351 / 1359
页数:9
相关论文
共 50 条
  • [1] Metabolic dysfunction in diabetic cardiomyopathy
    Isfort, Michael
    Stevens, Sarah C. W.
    Schaffer, Stephen
    Jong, Chian Ju
    Wold, Loren E.
    HEART FAILURE REVIEWS, 2014, 19 (01) : 35 - 48
  • [2] Mitochondrial Mechanisms in Diabetic Cardiomyopathy
    Gollmer, Johannes
    Zirlik, Andreas
    Bugger, Heiko
    DIABETES & METABOLISM JOURNAL, 2020, 44 (01) : 33 - 53
  • [3] Mitochondrial dysfunction and its impact on diabetic heart
    Verma, Suresh Kumar
    Garikipati, Venkata Naga Srikanth
    Kishore, Raj
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (05): : 1098 - 1105
  • [4] Effects of Bergamot Polyphenols on Mitochondrial Dysfunction and Sarcoplasmic Reticulum Stress in Diabetic Cardiomyopathy
    Maiuolo, Jessica
    Carresi, Cristina
    Gliozzi, Micaela
    Musolino, Vincenzo
    Scarano, Federica
    Coppoletta, Anna Rita
    Guarnieri, Lorenza
    Nucera, Saverio
    Scicchitano, Miriam
    Bosco, Francesca
    Ruga, Stefano
    Zito, Maria Caterina
    Macri, Roberta
    Cardamone, Antonio
    Serra, Maria
    Mollace, Rocco
    Tavernese, Annamaria
    Mollace, Vincenzo
    NUTRIENTS, 2021, 13 (07)
  • [5] The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy
    Tao, Li-Chan
    Wang, Ting-ting
    Zheng, Lu
    Hua, Fei
    Li, Jian-Jun
    BIOMOLECULES & THERAPEUTICS, 2022, 30 (05) : 399 - 408
  • [6] Mitochondrial NAD+/NADH Redox State and Diabetic Cardiomyopathy
    Berthiaume, Jessica M.
    Kurdys, Jacob G.
    Muntean, Danina M.
    Rosca, Mariana G.
    ANTIOXIDANTS & REDOX SIGNALING, 2019, 30 (03) : 375 - 398
  • [7] Diabetic cardiomyopathy revisited
    Boudina, Sihem
    Abel, E. Dale
    CIRCULATION, 2007, 115 (25) : 3213 - 3223
  • [8] Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
    Evangelista, Isabella
    Nuti, Ranuccio
    Picchioni, Tommaso
    Dotta, Francesco
    Palazzuoli, Alberto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13)
  • [9] Metabolic remodelling in diabetic cardiomyopathy
    Chong, Cher-Rin
    Clarke, Kieran
    Levelt, Eylem
    CARDIOVASCULAR RESEARCH, 2017, 113 (04) : 422 - 430
  • [10] Metabolic dysfunction in diabetic cardiomyopathy
    Michael Isfort
    Sarah C. W. Stevens
    Stephen Schaffer
    Chian Ju Jong
    Loren E. Wold
    Heart Failure Reviews, 2014, 19 : 35 - 48